CS Medica A/S (8G8.F)

0.5940 +0.1210 (+25.58%) At close: 04:25PM CEST

CS Medica A/S

Indiakaj 10
Copenhagen 2100
Denmark
45 70 70 73 37
https://www.cs-medica.com

Sector(s): Healthcare
Industry: Medical Devices
Full-time employees: 9

Key executives

Name	Title	Pay	Exercised	Year born
Ms. Lone Henriksen	CEO, Chief Scientific Officer & Founder	128.7k	N/A	1970
Ms. Gitte Lund Henriksen	Founder, CFO, CIO & Director	128.84k	N/A	1967
Ms. Heidi Ahlefeldt-Laurvig	COO & Chief Marketing Officer	N/A	N/A	1973
Ms. Cathy Bendix Jolibois	Chief Sales Manager	N/A	N/A	1971
Mikkel Raahauge Nielsen	C C O	N/A	N/A	1985
Ms. Suzan Al-shuweli	CQO & PRRC	N/A	N/A	1984
Mr. Kamlesh Vora	Managing Director of Cannordic India	N/A	N/A	N/A

Amounts are as of 31 December 2020, and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in EUR.

Description

CS MEDICA A/S develops, manufactures, and commercializes over the counter medical products containing cannabinoids for the treatment of psoriasis and arthritis. It offers gels for psoriasis, arthritis, protective nasal, and wound healing; and CBD anti-hair loss serum, as well as sleep nasal sprays and pain patches. The company primarily offers its products under the CANNASEN brand name. It also acts as a distributor of other cosmeceuticals and natural cosmetics in the Nordic region. The company was incorporated in 2011 and is based in Copenhagen, Denmark.

Corporate governance

CS Medica A/S’s ISS governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.